ATE536993T1 - Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten - Google Patents

Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten

Info

Publication number
ATE536993T1
ATE536993T1 AT03705645T AT03705645T ATE536993T1 AT E536993 T1 ATE536993 T1 AT E536993T1 AT 03705645 T AT03705645 T AT 03705645T AT 03705645 T AT03705645 T AT 03705645T AT E536993 T1 ATE536993 T1 AT E536993T1
Authority
AT
Austria
Prior art keywords
nanoparticles
amine
superparamagnetized
bioconjugates
synthesis
Prior art date
Application number
AT03705645T
Other languages
English (en)
Inventor
Debra Gaw
Lee Josephson
Original Assignee
Visen Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visen Medical Inc filed Critical Visen Medical Inc
Application granted granted Critical
Publication of ATE536993T1 publication Critical patent/ATE536993T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1854—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polyvinylpyrrolidone, polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT03705645T 2002-01-02 2003-01-02 Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten ATE536993T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34523302P 2002-01-02 2002-01-02
PCT/US2003/000051 WO2003057175A2 (en) 2002-01-02 2003-01-02 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor

Publications (1)

Publication Number Publication Date
ATE536993T1 true ATE536993T1 (de) 2011-12-15

Family

ID=23354146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03705645T ATE536993T1 (de) 2002-01-02 2003-01-02 Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten

Country Status (5)

Country Link
US (2) US20030124194A1 (de)
EP (1) EP1469989B1 (de)
AT (1) ATE536993T1 (de)
AU (1) AU2003207438A1 (de)
WO (1) WO2003057175A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536993T1 (de) * 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
US6797380B2 (en) * 2002-07-31 2004-09-28 General Electric Company Nanoparticle having an inorganic core
US7563507B2 (en) * 2002-08-16 2009-07-21 University Of Massachusetts Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
US20080102036A1 (en) * 2003-06-04 2008-05-01 Poss Kirtland G Biocompatible Fluorescent Silicon Nanoparticles
US20050014851A1 (en) * 2003-07-18 2005-01-20 Eastman Kodak Company Colloidal core-shell assemblies and methods of preparation
JP2007505311A (ja) * 2003-09-09 2007-03-08 コニンクリユケ フィリップス エレクトロニクス エヌ．ブイ． 検体を検出するためのナノ粒子
ES2242528B1 (es) 2004-03-25 2006-12-01 Consejo Sup. Investig. Cientificas Nanoparticulas magneticas de metales nobles.
US20060293396A1 (en) * 2005-01-14 2006-12-28 Eastman Kodak Company Amine polymer-modified nanoparticulate carriers
US8288169B2 (en) * 2005-01-21 2012-10-16 Argylla Technologies Surface mediated self-assembly of nanoparticles
EP1721603A1 (de) * 2005-05-11 2006-11-15 Albert-Ludwigs-Universität Freiburg Nanopartikel geeignet für Biokonjugation
JP5416970B2 (ja) 2005-09-02 2014-02-12 ビセン メディカル， インコーポレイテッド ニコチン酸及びピコリン酸誘導近赤外線蛍光団
CN101296927A (zh) 2005-09-02 2008-10-29 Visen医药公司 生物相容的含n,n-二取代磺酰胺的荧光染料标记
US7947256B2 (en) * 2005-09-02 2011-05-24 Visen Medical, Inc. Biocompatible fluorescent imaging agents
AU2006301847B2 (en) 2005-10-14 2011-11-17 Vive Nano Inc. Composite nanoparticles, nanoparticles and methods for producing same
WO2007064301A1 (en) * 2005-11-30 2007-06-07 Agency For Science, Technology And Research Nanoparticle and methods therefor
US20070140974A1 (en) * 2005-12-15 2007-06-21 General Electric Company Targeted nanoparticles for magnetic resonance imaging
WO2007136413A2 (en) * 2005-12-22 2007-11-29 Visen Medical, Inc. Biocompatible fluorescent metal oxide nanoparticles
WO2007099289A1 (en) * 2006-02-28 2007-09-07 Medical Research Council Targeted iron oxide nanoparticles
US20070225632A1 (en) * 2006-03-21 2007-09-27 David Rauser Hydratable polymeric ester matrix for drug electrotransport
EP2000484B1 (de) * 2006-03-27 2011-11-30 Tokyo Institute of Technology Verfahren zur herstellung von polymerbeschichtetem ferromagnetischem teilchen und polymerbeschichtetes ferromagnetisches teilchen
US20080008654A1 (en) * 2006-07-07 2008-01-10 Boston Scientific Scimed, Inc. Medical devices having a temporary radiopaque coating
US8333993B1 (en) 2006-12-29 2012-12-18 University Of Central Florida Research Foundation, Inc. Synthesis of polymer coated ceria nanoparticles for biomedical applications
US8221721B2 (en) * 2007-02-09 2012-07-17 Visen Medical, Inc. Polycyclo dyes and use thereof
US20080193766A1 (en) * 2007-02-13 2008-08-14 Northern Nanotechnologies Control of Transport to and from Nanoparticle Surfaces
WO2008109832A2 (en) * 2007-03-08 2008-09-12 Visen Medical, Inc. Viable near-infrared fluorochrome labeled cells and methods of making and using same
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US8409463B1 (en) 2007-07-16 2013-04-02 University Of Central Florida Research Foundation, Inc. Aqueous method for making magnetic iron oxide nanoparticles
US9057094B1 (en) 2007-10-25 2015-06-16 University Of Central Florida Research Foundation, Inc. Nanoparticle-mediated methods for antimicrobial susceptibility testing of bacteria
ES2658852T3 (es) 2008-01-18 2018-03-12 Visen Medical, Inc. Agentes de imaginología fluorescentes
US8236284B1 (en) 2008-04-02 2012-08-07 University Of Central Florida Research Foundation, Inc. Multimodal, multifunctional polymer coated nanoparticles
US7645318B2 (en) * 2008-05-07 2010-01-12 Vive Nano, Inc. Producing nanoparticles using nanoscale polymer templates
US8324125B2 (en) * 2009-09-03 2012-12-04 The United States Of America As Represented By The Administrator Of The U.S. Environmental Protection Agency Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst
DK2494075T3 (en) 2009-10-30 2018-07-23 Univ Northwestern TABLE-MANAGED NANOCONJUGATES
JP2013526616A (ja) 2010-05-26 2013-06-24 ザ ジェネラル ホスピタル コーポレイション 磁性ナノ粒子
AU2012253502C1 (en) 2011-05-09 2017-12-14 Visen Medical, Inc. Carbonic anhydrase targeting agents and methods of using same
US9109249B2 (en) 2011-05-19 2015-08-18 University Of Central Florida Research Foundation, Inc. Microbe detection via hybridizing magnetic relaxation nanosensors
US9958416B2 (en) 2011-11-23 2018-05-01 The General Hospital Corporation Analyte detection using magnetic hall effect
US9375493B2 (en) 2012-03-30 2016-06-28 Visen Medical, Inc. Bacterial imaging agents and methods of using same
KR20130113575A (ko) * 2012-04-06 2013-10-16 서울대학교산학협력단 산화철 나노복합체와 이를 포함하는 자기공명영상 ｔ2 조영제 및 이들의 제조 방법
KR101380900B1 (ko) * 2012-05-08 2014-04-10 포항공과대학교 산학협력단 나이트로 방향족 폭발물의 안정적인 검출을 위한 나노입자 표면 분자체의 합성과 이를 이용한 폭발물 검출 센서
EP2864051B1 (de) 2012-06-25 2020-09-23 The General Hospital Corporation Sortieren von partikeln unter verwendung von starken magnetfeldern
JP6370785B2 (ja) 2012-08-15 2018-08-08 ビセン メディカル， インコーポレイテッド 前立腺がんイメージングのための前立腺特異的抗原薬剤およびその使用方法
CA2904758A1 (en) * 2013-03-14 2014-09-25 Peroxyium, Inc., Delaware C Corp. Method of enhancing the biodistribution and tissue targeting properties of therapeutic ceo2 particles via nano-encapsulation and coating
CN105339436B (zh) 2013-03-15 2018-05-25 文森医学公司 4,4-二取代环己基桥连七甲川花菁染料及其应用
JP6606487B2 (ja) 2013-03-15 2019-11-13 ビセン メディカル， インコーポレイテッド ｉｎｖｉｔｒｏおよびｉｎｖｉｖｏイメージングおよび検出のための置換シラキサンテニウム赤色〜近赤外蛍光色素
US20140342388A1 (en) * 2013-04-04 2014-11-20 Yang Cai Reagent for labeling primary amine groups in proteins
CN104297219A (zh) * 2013-07-16 2015-01-21 上海乐宇生物科技有限公司 高灵敏度的三磷酸腺苷检测方法
EP3058316B1 (de) 2013-10-18 2019-03-13 The General Hospital Corporation Mikrofluidische sortierung unter verwendung von magnetfeldern mit hohem gradienten
WO2015173729A1 (en) * 2014-05-12 2015-11-19 Qi, Huan Method and system for analyte sensing
WO2016065218A1 (en) 2014-10-23 2016-04-28 Corning Incorporated Polymer-encapsulated magnetic nanoparticles
JP6744302B2 (ja) 2014-11-03 2020-08-19 ザ ジェネラル ホスピタル コーポレイション ミクロ流体装置における粒子の分類
EP3338806A1 (de) * 2016-12-21 2018-06-27 Université de Namur Verfahren zur funktionalisierung von nanopartikeln
EP3566720A1 (de) * 2018-05-08 2019-11-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Nanopartikel mit nichtkovalent gebundenen targeting-teilen zur verwendung in einem therapeutischen verfahren und zur nichtmedizinischen verwendung
EP4086629A4 (de) 2019-12-31 2023-09-06 Universidad de Santiago de Chile System und verfahren zum detektieren eines biologischen analyten, einschliesslich eines mikroorganismus, durch eine veränderung der magnetischen eigenschaft eines substrats, unter verwendung von superparamagnetischen nanopartikeln
CN119034687B (zh) * 2024-07-19 2026-02-03 国氟新材料(广东)有限公司 一种含氟污泥脱水的可重复使用助滤剂及其制备方法

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913521B2 (ja) * 1975-06-19 1984-03-30 メイトウサンギヨウ カブシキガイシヤ 磁性酸化鉄・デキストラン複合体の製造法
US4219335A (en) * 1978-09-18 1980-08-26 E. I. Du Pont De Nemours And Company Immunochemical testing using tagged reagents
US4369226A (en) * 1979-03-19 1983-01-18 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4438239A (en) * 1981-03-30 1984-03-20 California Institute Of Technology Microsphere coated substrate containing reactive aldehyde groups
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
NO155316C (no) * 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4628037A (en) * 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US5627027A (en) * 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US5569587A (en) * 1986-04-18 1996-10-29 Carnegie Mellon University Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US5262176A (en) * 1986-07-03 1993-11-16 Advanced Magnetics, Inc. Synthesis of polysaccharide covered superparamagnetic oxide colloids
US5478576A (en) * 1986-07-03 1995-12-26 Advanced Magnetics, Inc. Arabinogalactan derivatives and uses thereof
US5395688A (en) * 1987-10-26 1995-03-07 Baxter Diagnostics Inc. Magnetically responsive fluorescent polymer particles
US5512439A (en) * 1988-11-21 1996-04-30 Dynal As Oligonucleotide-linked magnetic particles and uses thereof
US4981977A (en) * 1989-06-09 1991-01-01 Carnegie-Mellon University Intermediate for and fluorescent cyanine dyes containing carboxylic acid groups
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
JP2726520B2 (ja) * 1989-10-20 1998-03-11 名糖産業株式会社 有機磁性複合体
US5164297A (en) * 1990-05-03 1992-11-17 Advanced Magnetics Inc. Solvent mediated relaxation assay system
EP0543020B1 (de) * 1991-06-11 1997-12-29 Meito Sangyo Kabushiki Kaisha Oxidierte zusammensetzung, enthaltend ein wasserlösliches carboxypolysaccharid und magnetisches eisenoxid
US5445970A (en) * 1992-03-20 1995-08-29 Abbott Laboratories Magnetically assisted binding assays using magnetically labeled binding members
ES2199226T3 (es) * 1992-09-04 2004-02-16 The General Hospital Corporation Polimeros biocompatibles que contienen mitades diagnosticas o terapeuticas.
US5808044A (en) * 1993-01-22 1998-09-15 Pharmacia Biotech Inc. Indocarbocyanine and benzindocarbocyanine phosphoramidites
ATE191086T1 (de) * 1994-07-27 2000-04-15 Pilgrimm Herbert Superparamagnetische teilchen, verfahren zur herstellung und deren verwendung
US6127134A (en) * 1995-04-20 2000-10-03 Carnegie Mellon University Difference gel electrophoresis using matched multiple dyes
US5539658A (en) * 1995-05-16 1996-07-23 Minnesota Mining And Manufacturing Company Electronic presentation system using portable storage media
US6008373A (en) * 1995-06-07 1999-12-28 Carnegie Mellon University Fluorescent labeling complexes with large stokes shift formed by coupling together cyanine and other fluorochromes capable of resonance energy transfer
IT1276833B1 (it) * 1995-10-09 1997-11-03 Sorin Biomedica Cardio Spa Coloranti fluorescenti della famiglia della solfo benz e indocianina
US6004536A (en) * 1995-11-14 1999-12-21 Molecular Probes, Inc. Lipophilic cyanine dyes with enchanced aqueous solubilty
WO1997021452A2 (en) 1995-12-14 1997-06-19 Advanced Magnetics, Inc. Macromolecular prodrugs of nucleotide analogs
JP2000508709A (ja) 1996-04-19 2000-07-11 アマーシャム・ファルマシア・バイオテック・ユーケイ・リミテッド スクアラート染料類および蛍光配列決定法におけるそれらの使用
FR2749082B1 (fr) * 1996-05-24 1998-06-26 Bio Merieux Particules superparamagnetiques et monodispersees
US6316265B1 (en) * 1997-03-13 2001-11-13 Abbott Laboratories Determination of % glycated hemoglobin
US5877310A (en) * 1997-04-25 1999-03-02 Carnegie Mellon University Glycoconjugated fluorescent labeling reagents
US6248539B1 (en) * 1997-09-05 2001-06-19 The Scripps Research Institute Porous semiconductor-based optical interferometric sensor
US6074884A (en) * 1997-10-09 2000-06-13 Coulter International Corp. Stable protein-nickel particles and methods of production and use thereof
US6046585A (en) * 1997-11-21 2000-04-04 Quantum Design, Inc. Method and apparatus for making quantitative measurements of localized accumulations of target particles having magnetic particles bound thereto
US6133445A (en) * 1997-12-17 2000-10-17 Carnegie Mellon University Rigidized trimethine cyanine dyes
DE69815282T2 (de) * 1997-12-25 2004-05-06 Tosoh Corp., Shinnanyo Magnetischer Träger, seine Herstellung, und Verfahren zum Extrahieren von Nukleinsäuren
EP1078023B1 (de) 1998-04-08 2011-01-05 Corporation Luminex Lumineszierende verbindungen
US6002003A (en) * 1998-04-14 1999-12-14 Beckman Instruments, Inc. Cyanine dye activating group with improved coupling selectivity
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
US6083486A (en) * 1998-05-14 2000-07-04 The General Hospital Corporation Intramolecularly-quenched near infrared fluorescent probes
DK1169062T3 (da) 1999-04-09 2010-01-25 Amag Pharmaceuticals Inc Varmestabile overtrukne kolloide jernoxider
EP1065250B1 (de) 1999-07-02 2004-12-08 Visen Medical, Inc. Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied
US6767635B1 (en) * 1999-09-14 2004-07-27 Biomedical Apherese Systeme Gmbh Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
WO2001021624A1 (en) 1999-09-20 2001-03-29 Fuji Photo Film Co., Ltd. Compounds for fluorescence labeling
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6734000B2 (en) * 2000-10-12 2004-05-11 Regents Of The University Of California Nanoporous silicon support containing macropores for use as a bioreactor
US6615063B1 (en) * 2000-11-27 2003-09-02 The General Hospital Corporation Fluorescence-mediated molecular tomography
EP1209205A1 (de) * 2000-11-28 2002-05-29 Innosense S.r.l. Verbesserte Verfahren und Methode zur Herstellung von asymmetrischen monofunktionalisierten Indocyaninmarkern sowie erhaltene Verbindungen
EP1221465A1 (de) * 2001-01-03 2002-07-10 Innosense S.r.l. Symmetrische, monofunktionalisierte Polymethinfarbstoffe als Markierungsreagenzien
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
US20030092029A1 (en) * 2001-06-06 2003-05-15 Lee Josephson Magneitc-nanoparticle conjugates and methods of use
SK287806B6 (sk) * 2001-06-28 2011-10-04 Pfizer Products Inc. Triamid-substituované indoly, benzofurány a benzotiofény ako inhibítory mikrozómového proteínu prenášajúceho triglyceridu (MTP) a/alebo sekrécie apolipoproteínu B (Apo B)
US7463615B2 (en) 2001-07-13 2008-12-09 Qualcomm, Incorporated System and method for extended SIP headers for CDMA parameters
ATE536993T1 (de) 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
WO2003061711A2 (en) * 2002-01-16 2003-07-31 Visen Medical, Inc. Chromophore probes for optical imaging
AU2003225763A1 (en) * 2002-03-11 2003-09-29 Visen Medical, Inc. Optical imaging probes
US7189417B2 (en) * 2002-05-01 2007-03-13 The Trustees Of The University Of Pennsylvania Nanometer-sized carrier medium
US20060169843A1 (en) * 2002-05-14 2006-08-03 Barrs Chris C Release connectors (quick release pull tab)
WO2003102558A1 (en) 2002-06-04 2003-12-11 Visen Medical, Inc. Imaging volumes with arbitrary geometries in contact and non-contact tomography
US7303741B2 (en) 2002-09-23 2007-12-04 General Electric Company Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism
AU2003303954A1 (en) 2002-10-25 2004-10-11 Emory University Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
US20080102036A1 (en) * 2003-06-04 2008-05-01 Poss Kirtland G Biocompatible Fluorescent Silicon Nanoparticles
WO2005017539A2 (en) 2003-08-14 2005-02-24 The General Hospital Corporation Imaging pathology
WO2006010083A2 (en) 2004-07-08 2006-01-26 Molecular Therapeutics, Inc. Biodegradable nanoparticles
KR20070052747A (ko) 2004-09-10 2007-05-22 도레이 가부시끼가이샤 의약품제제
US20070292688A1 (en) 2005-08-18 2007-12-20 Eastman Kodak Company Silylamine modified nanoparticulate carriers
JP5416970B2 (ja) 2005-09-02 2014-02-12 ビセン メディカル， インコーポレイテッド ニコチン酸及びピコリン酸誘導近赤外線蛍光団
US7947256B2 (en) 2005-09-02 2011-05-24 Visen Medical, Inc. Biocompatible fluorescent imaging agents
CN101296927A (zh) 2005-09-02 2008-10-29 Visen医药公司 生物相容的含n,n-二取代磺酰胺的荧光染料标记
EP2308513A3 (de) 2005-11-16 2011-11-23 Signalomics GmbH Fluoreszenz-Nanopartikel
WO2007136413A2 (en) 2005-12-22 2007-11-29 Visen Medical, Inc. Biocompatible fluorescent metal oxide nanoparticles

Also Published As

Publication number Publication date
WO2003057175A3 (en) 2003-11-13
EP1469989B1 (de) 2011-12-14
WO2003057175A2 (en) 2003-07-17
AU2003207438A1 (en) 2003-07-24
AU2003207438A8 (en) 2003-07-24
EP1469989A4 (de) 2006-07-05
US20090068115A1 (en) 2009-03-12
US20030124194A1 (en) 2003-07-03
US8420055B2 (en) 2013-04-16
EP1469989A2 (de) 2004-10-27

Similar Documents

Publication Publication Date Title
ATE536993T1 (de) Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
Shi et al. Dendrimer‐entrapped gold nanoparticles as a platform for cancer‐cell targeting and imaging
CN102313725B (zh) 一种溶菌酶分子印迹-量子点纳米荧光探针的制备方法
Li et al. Surface molecular imprinting onto fluorescein-coated magnetic nanoparticles via reversible addition fragmentation chain transfer polymerization: A facile three-in-one system for recognition and separation of endocrine disrupting chemicals
Badri et al. Modification of graphene/graphene oxide with polymer brushes using controlled/living radical polymerization
CN106475068B (zh) 苯硼酸功能化的氧化石墨烯复合纳米材料及其制备和应用
CN102323412A (zh) 一种拉曼编码微球的用途及利用拉曼编码微球检测肿瘤标志物的方法
CN106540668B (zh) 磁性亲水分子印迹复合材料及其制备方法
Yu et al. Advances in synthesis and application of amphoteric polymer-based water treatment agents
Ma et al. Multi-targeting magnetic hyaluronan capsules efficiently capturing circulating tumor cells
Bayrakci et al. Novel humic acid-bonded magnetite nanoparticles for protein immobilization
Berghaus et al. Productive encounter: molecularly imprinted nanoparticles prepared using magnetic templates
Yang et al. pH-Responsive magnetic nanospheres for the reversibly selective capture and release of glycoproteins
Tao et al. Modification of multi-wall carbon nanotube surfaces with poly (amidoamine) dendrons: synthesis and metal templating
Peiris et al. Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry
Huang et al. Facile syntheses of cucurbit [6] uril-anchored polymers and their noncovalent modification
JP2019073673A (ja) 自己修復性ゲル
Sedlacek et al. Multifunctional poly (2-ethyl-2-oxazoline) copolymers containing dithiolane and pentafluorophenyl esters as effective reactive linkers for gold surface coatings
CN103435781A (zh) 一种环氧树脂固化剂及其制备方法与应用
Mao et al. Self-assembled supramolecular immunomagnetic nanoparticles through π–π stacking strategy for the enrichment of circulating tumor cells
CN119912937A (zh) 一种Tosyl修饰磁性时间分辨荧光微球及制备方法和应用
Li et al. A study of electrochemical sensor based on BHb-imprinted magnetic nanoparticles
Wang et al. Synergetic enhancement: Imprinted magnetic microspheres based on the thiol-ene-amine conjugation and metal coordination for selective recognition of BSA
CN112552204A (zh) 丙烯酰-n-（2-硝基苄基）甘氨酰胺光敏单体及其制备方法
CN105885049B (zh) 一种α-鹅膏毒肽分子印迹材料制备方法